Sano H, Sunazuka T, Tanaka H, Yamashita K, Okachi R, Omura S
J Antibiot (Tokyo). 1984 Jul;37(7):760-72. doi: 10.7164/antibiotics.37.760.
3'',4''-Diacylates and 3,3'',4''-triacylates of spiramycin I were synthesized and evaluated by the four parameters, MIC against bacteria, affinity to ribosomes, retention time in HPLC and therapeutic effect. Among them, 3,3'',4''-tri-O-propionyl and 3,4''-di-O-acetyl-3''-O-butyryl-spiramycin I were the most active in vivo, which were superior to acetylspiramycin.
合成了螺旋霉素I的3'',4''-二酰化物和3,3'',4''-三酰化物,并通过四个参数进行评估,即对细菌的最低抑菌浓度(MIC)、对核糖体的亲和力、在高效液相色谱(HPLC)中的保留时间和治疗效果。其中,3,3'',4''-三-O-丙酰基螺旋霉素I和3,4''-二-O-乙酰基-3''-O-丁酰基螺旋霉素I在体内活性最高,优于乙酰螺旋霉素。